![ASCP10-Don't use strong CYP3A4 and P-glycoprotein inhibitors or inducers with Direct Oral Anticoagulants (DOACs) and periodically assess the medication regimen for such drug-drug interactions. | Choosing Wisely ASCP10-Don't use strong CYP3A4 and P-glycoprotein inhibitors or inducers with Direct Oral Anticoagulants (DOACs) and periodically assess the medication regimen for such drug-drug interactions. | Choosing Wisely](https://www.choosingwisely.org/wp-content/uploads/2021/05/ASCP-CLR-logo-NoTag-RGB-01smaller.png)
ASCP10-Don't use strong CYP3A4 and P-glycoprotein inhibitors or inducers with Direct Oral Anticoagulants (DOACs) and periodically assess the medication regimen for such drug-drug interactions. | Choosing Wisely
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment | Journal of Medicinal Chemistry
![Apixaban (Eliquis®) – Drug-Drug-Interaction Considerations in COVID-19 Patients with Coagulation Abnormalities - Anesthesia Patient Safety Foundation Apixaban (Eliquis®) – Drug-Drug-Interaction Considerations in COVID-19 Patients with Coagulation Abnormalities - Anesthesia Patient Safety Foundation](https://www.apsf.org/wp-content/uploads/ddi/2020/apixaban-direct-factor-xa-inhibitor-1024x576.jpg)
Apixaban (Eliquis®) – Drug-Drug-Interaction Considerations in COVID-19 Patients with Coagulation Abnormalities - Anesthesia Patient Safety Foundation
![Frontiers | Clinical Perspective of FDA Approved Drugs With P-Glycoprotein Inhibition Activities for Potential Cancer Therapeutics Frontiers | Clinical Perspective of FDA Approved Drugs With P-Glycoprotein Inhibition Activities for Potential Cancer Therapeutics](https://www.frontiersin.org/files/Articles/561936/fonc-10-561936-HTML-r1/image_m/fonc-10-561936-t002.jpg)
Frontiers | Clinical Perspective of FDA Approved Drugs With P-Glycoprotein Inhibition Activities for Potential Cancer Therapeutics
![SciELO - Brasil - Overview of P-glycoprotein inhibitors: a rational outlook Overview of P-glycoprotein inhibitors: a rational outlook SciELO - Brasil - Overview of P-glycoprotein inhibitors: a rational outlook Overview of P-glycoprotein inhibitors: a rational outlook](https://minio.scielo.br/documentstore/2175-9790/TjKWXnrBxMvtPZWgNMDFxMM/b6b81950a2e296abac549644d5c6848b44165ac2.jpg)
SciELO - Brasil - Overview of P-glycoprotein inhibitors: a rational outlook Overview of P-glycoprotein inhibitors: a rational outlook
![Exploring new Horizons in overcoming P-glycoprotein-mediated multidrug-resistant breast cancer via nanoscale drug delivery platforms - ScienceDirect Exploring new Horizons in overcoming P-glycoprotein-mediated multidrug-resistant breast cancer via nanoscale drug delivery platforms - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2590257121000419-gr2.jpg)
Exploring new Horizons in overcoming P-glycoprotein-mediated multidrug-resistant breast cancer via nanoscale drug delivery platforms - ScienceDirect
![Frontiers | Clinical Perspective of FDA Approved Drugs With P-Glycoprotein Inhibition Activities for Potential Cancer Therapeutics Frontiers | Clinical Perspective of FDA Approved Drugs With P-Glycoprotein Inhibition Activities for Potential Cancer Therapeutics](https://www.frontiersin.org/files/Articles/561936/fonc-10-561936-HTML-r1/image_m/fonc-10-561936-g001.jpg)
Frontiers | Clinical Perspective of FDA Approved Drugs With P-Glycoprotein Inhibition Activities for Potential Cancer Therapeutics
![SciELO - Brasil - Overview of P-glycoprotein inhibitors: a rational outlook Overview of P-glycoprotein inhibitors: a rational outlook SciELO - Brasil - Overview of P-glycoprotein inhibitors: a rational outlook Overview of P-glycoprotein inhibitors: a rational outlook](https://minio.scielo.br/documentstore/2175-9790/TjKWXnrBxMvtPZWgNMDFxMM/98b221523fd2d65628db61532c4065d0e2b231f4.jpg)
SciELO - Brasil - Overview of P-glycoprotein inhibitors: a rational outlook Overview of P-glycoprotein inhibitors: a rational outlook
![Table 1 from Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy. | Semantic Scholar Table 1 from Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b533fdc9bb24a5477f10095337cfc2db4edee6ce/3-Table1-1.png)
Table 1 from Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy. | Semantic Scholar
![Bypassing P-Glycoprotein Drug Efflux Mechanisms: Possible Applications in Pharmacoresistant Schizophrenia Therapy Bypassing P-Glycoprotein Drug Efflux Mechanisms: Possible Applications in Pharmacoresistant Schizophrenia Therapy](https://static-02.hindawi.com/articles/bmri/volume-2015/484963/figures/484963.fig.002.jpg)
Bypassing P-Glycoprotein Drug Efflux Mechanisms: Possible Applications in Pharmacoresistant Schizophrenia Therapy
![SciELO - Brasil - Overview of P-glycoprotein inhibitors: a rational outlook Overview of P-glycoprotein inhibitors: a rational outlook SciELO - Brasil - Overview of P-glycoprotein inhibitors: a rational outlook Overview of P-glycoprotein inhibitors: a rational outlook](https://minio.scielo.br/documentstore/2175-9790/TjKWXnrBxMvtPZWgNMDFxMM/05530cfb309b03172203d0f52ba052ed9fd5e2e9.jpg)
SciELO - Brasil - Overview of P-glycoprotein inhibitors: a rational outlook Overview of P-glycoprotein inhibitors: a rational outlook
![Table 1.4 from P-glycoprotein inhibition as a strategy to increase drug delivery across the blood-brain barrier: focus on antidepressants | Semantic Scholar Table 1.4 from P-glycoprotein inhibition as a strategy to increase drug delivery across the blood-brain barrier: focus on antidepressants | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/cb07bdccd7c7e764d8e619d6a15ecce23b7d8307/49-Table1.4-1.png)
Table 1.4 from P-glycoprotein inhibition as a strategy to increase drug delivery across the blood-brain barrier: focus on antidepressants | Semantic Scholar
![Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells | Scientific Reports Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-018-19325-x/MediaObjects/41598_2018_19325_Fig1_HTML.jpg)
Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells | Scientific Reports
![Cardio-Oncology Drug Interactions: A Scientific Statement From the American Heart Association | Circulation Cardio-Oncology Drug Interactions: A Scientific Statement From the American Heart Association | Circulation](https://www.ahajournals.org/cms/asset/418c989e-28f2-4bae-8b4e-00c7f6215a14/cir.0000000000001056.fig01.jpg)
Cardio-Oncology Drug Interactions: A Scientific Statement From the American Heart Association | Circulation
![Bypassing P-Glycoprotein Drug Efflux Mechanisms: Possible Applications in Pharmacoresistant Schizophrenia Therapy Bypassing P-Glycoprotein Drug Efflux Mechanisms: Possible Applications in Pharmacoresistant Schizophrenia Therapy](https://static-02.hindawi.com/articles/bmri/volume-2015/484963/figures/484963.fig.001b.jpg)
Bypassing P-Glycoprotein Drug Efflux Mechanisms: Possible Applications in Pharmacoresistant Schizophrenia Therapy
![Table 2 from Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy. | Semantic Scholar Table 2 from Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b533fdc9bb24a5477f10095337cfc2db4edee6ce/10-Table2-1.png)